| __timestamp | Galapagos NV | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 19586000 |
| Thursday, January 1, 2015 | 129714000 | 29135000 |
| Friday, January 1, 2016 | 139574000 | 42791000 |
| Sunday, January 1, 2017 | 218502000 | 49577000 |
| Monday, January 1, 2018 | 322876000 | 89209000 |
| Tuesday, January 1, 2019 | 427320000 | 69099000 |
| Wednesday, January 1, 2020 | 523667000 | 75961000 |
| Friday, January 1, 2021 | 491707000 | 90467000 |
| Saturday, January 1, 2022 | 515083000 | 74552000 |
| Sunday, January 1, 2023 | 241294000 | 91593000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Galapagos NV and Supernus Pharmaceuticals, Inc. have demonstrated distinct strategies in their R&D allocations.
From 2014 to 2023, Galapagos NV consistently prioritized R&D, with expenditures peaking in 2020 at over 500% of their 2014 levels. This robust investment underscores their commitment to pioneering new treatments and maintaining a competitive edge.
Supernus Pharmaceuticals, while more conservative, has shown a steady increase in R&D spending, nearly quadrupling their 2014 investment by 2023. This gradual approach reflects a balanced strategy, focusing on sustainable growth and innovation.
Both companies exemplify the critical role of R&D in driving pharmaceutical advancements, albeit through different financial strategies.
Comparing Innovation Spending: Eli Lilly and Company and Galapagos NV
Research and Development Investment: Pfizer Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development Investment: Sanofi vs Galapagos NV
Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Galapagos NV: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. or Supernus Pharmaceuticals, Inc.: Who Invests More in Innovation?
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Veracyte, Inc. vs Galapagos NV
Research and Development Investment: Catalyst Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Wave Life Sciences Ltd. or Galapagos NV: Who Invests More in Innovation?